Effect of Vojta Therapy on Motor Control in Children With Attention Deficit Hyperactivity Disorder
1 other identifier
interventional
20
1 country
1
Brief Summary
ADHD is generally associated with significant comorbidities including motor disorders in up to 96% of cases. Within these, disturbances of balance and motor coordination that interfere with school learning and daily activities are present in 47% of school children with ADHD. Therefore, the aim of this research is to determine whether Vojta therapy is beneficial for the improvement of balance, postural control, hand-eye coordination and manipulative motor skills in children with ADHD, hyperactive and/or combined, aged 6-12 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2024
CompletedFirst Posted
Study publicly available on registry
November 1, 2024
CompletedStudy Start
First participant enrolled
November 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2025
CompletedMarch 7, 2025
March 1, 2025
2 months
October 31, 2024
March 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensory organisation test (NEUROCOM dynamic posturology)
This test is a commonly used research tool in the assessment of the sensory organisation of postural control and has previously been used in children. The system's force platform provides data on the movement of the centre of gravity. Both the platform and the environment can move in response to the anteroposterior displacement of the child's body under certain conditions of sensory override or conflict. The child is asked to stand upright, barefoot, with arms alongside the body, feet placed in a certain position on the platform, for 20sec, trying to remain as stable as possible during the 3 trials of each of the 6 conditions of the SOT. For their safety, the child shall be restrained by a harness. In each test, the system compares the child's displacement with its theoretical limits of stability, generating a score. The higher the value, the better the stability. The software also calculates an overall score from the scores obtained in each of the 6 conditions
15 minutes
Secondary Outcomes (3)
Paediatric Balance Scale
15 minutes
Bruininks-Oseretsky Test (abbreviated version)
10 minutes
Paediatric Quality of Life Questionnaire
10 minutes
Study Arms (2)
Experimental group
EXPERIMENTALThis group is treated according to Vojta therapy
Control group
OTHERThis group does not receive treatment
Interventions
The intervention is carried out using Vojta therapy for one month, with one session per day, 5 days a week. This therapy is carried out by an expert physiotherapist. Vojta therapy is a non-experimental, painless, non-invasive therapy with no adverse effects, which is based on triggering repeated motor reactions or innate movement patterns (reflex locomotion patterns) in the trunk and limbs based on defined stimuli and starting from specific postures. Both groups will undertake a pre-treatment assessment, a post-treatment assessment at the end of the one-month intervention period, and a final follow-up assessment one month after the end of the intervention.
Eligibility Criteria
You may qualify if:
- Have a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) of the combined or hyperkinetic type.
- Be between 6 and 12 years of age.
- Be under treatment with methylphenidate.
- IQ of 100 or higher.
- Have a normal neurological examination.
- Not dysmorphic.
You may not qualify if:
- Present a diagnosis of ADHD comorbid with other neuropsychiatric pathologies.
- Have a history of neurological or musculoskeletal disorders that are linked to a deficit in balance and/or postural control.
- Be under treatment with atomoxetine.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Rey Juan Carlos
Alcorcón, Madrid, 28922, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 31, 2024
First Posted
November 1, 2024
Study Start
November 30, 2024
Primary Completion
January 20, 2025
Study Completion
March 3, 2025
Last Updated
March 7, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share